Home/Filings/4/0001104659-22-043237
4//SEC Filing

CONTE LISA A 4

Accession 0001104659-22-043237

CIK 0001585608other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:31 PM ET

Size

7.6 KB

Accession

0001104659-22-043237

Insider Transaction Report

Form 4
Period: 2022-04-05
CONTE LISA A
DirectorCEO and President
Transactions
  • Exercise/Conversion

    Common Stock

    2022-04-05+45,00053,003 total
  • Award

    Restricted stock units

    2022-04-05+45,00090,000 total
    Common Stock (45,000 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
  • [F3]The restricted stock units were previously reported as covering 405,000 shares, but were adjusted to reflect the Reverse Stock Split. Such restricted stock units were granted on April 5, 2021 and vest in three equal annual installments beginning on April 5, 2022, the first anniversary of the grant date.

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001008377

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:31 PM ET
Size
7.6 KB